Therefore, we analyzed the Kaplan–Meier curve of BRCA and TGCT and found that a higher expression of SPA17 was related to a better survival outcome (Figures 2C, F), indicating that SPA17 was a prognostic biomarker of OS in BRCA and TGCT. This evidence concerns the gene SPA17 and testicular germ cell tumor.